Status:
TERMINATED
PACESETTER: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor
Lead Sponsor:
Northern California Institute of Research and Education
Collaborating Sponsors:
University of South Carolina
Medical University of South Carolina
Conditions:
Blood Pressure
Hypertension
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Program to Avoid Cerebrovascular Events through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor (PACESETTER) aims to assess the incorporation of its stroke intervention into 2 s...
Eligibility Criteria
Inclusion
- African American or non-Hispanic white
- history of stroke (within six months of symptom onset)
- uncontrolled HTN (SBP ≥ 130 mmHg at the last clinical encounter post-stroke prior to recruitment)
- owning a smartphone with a data plan
- able to take their own BP and self-administer medications.
Exclusion
- Any condition that would limit participation in follow up assessments including severe cognitive impairment/dementia
- severe global disability (modified Rankin Score ≥ 3)
- BMI\> 40kg/m\^2
- Not being able to speak, hear, or understand English
Key Trial Info
Start Date :
July 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03401489
Start Date
July 14 2020
End Date
February 28 2024
Last Update
December 11 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
NCIRE
San Francisco, California, United States, 94121
2
Medical University of South Carolina
Charleston, South Carolina, United States, 29425
3
University of South Carolina
Columbia, South Carolina, United States, 29203
4
Regional Medical Center: Orangeburg Hospital
Orangeburg, South Carolina, United States, 29118